19 April 2004 00:01 [Source: ICB Americas]
The European Union (EU) Commission has granted Archer Daniels Midland Company (ADM) novel foods authorization for the use of plant-derived sterols and sterol esters in specified food products.
The US Bankruptcy Court in New York has given Solutia Inc. a 90-day extension to propose a reorganization plan. Solutia had 120 days to propose the plan after filing for Chapter 11 bankruptcy protection in mid-December.
Polysciences Inc., a contract manufacturer of specialty chemicals and laboratory products, has bought Dream Cosmetics Inc. The acquisition doubles Polysciences’ contract manufacturing capabilities.
Insmed Inc. has acquired a lease to operate a recombinant protein manufacturing facility in Boulder, Colo., formerly operated by Baxter International. Insmed will produce its Phase III SomatoKine product at the site.
The US Patent and Trademark Office has approved Syngenta’s fifth transgenic patent. Three of the previously issued patents are the subject of a lawsuit Syngenta filed on July 25, 2002, against Monsanto, DeKalb Genetics, Pioneer Hi-Bred, Dow Agrosciences and Mycogen Seeds.
zuChem Inc., a supplier of glycochemicals and other specialized sugars, has raised more than $500,000 in a second close of its series A financing.
Nanotechnologies Inc. and Technanogy Materials Development have agreed to merge their assets, strengthening their nanoaluminum businesses.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.